2.43
-0.07 (-2.8%)
-0.07 (-2.8%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acer Therapeutics Inc | ACER | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.07 | -2.8% | 2.43 | 13:24:49 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 2.42 | 2.53 | 2.53 | 2.50 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.42 | 2.44 | 0.02 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 350 | 83,460 | $ 2.48 | $ 206,879 | 468,422 | 1.08 - 7.25 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:25:36 | 25 | $ 2.44 | USD |
Acer Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 28.95M | 11.91M | 7.34M | $ - | $ - | -2.91 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 223.57k | - |
Acer Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACER Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.47 | 2.74 | 2.42 | 2.56 | 175,966 | -0.04 | -1.62% |
| 1 Month | 2.84 | 2.94 | 2.15 | 2.51 | 181,743 | -0.41 | -14.44% |
| 3 Months | 3.44 | 5.84 | 2.15 | 3.86 | 454,165 | -1.01 | -29.36% |
| 6 Months | 1.30 | 7.05 | 1.08 | 3.68 | 304,675 | 1.13 | 86.92% |
| 1 Year | 3.65 | 7.25 | 1.08 | 3.68 | 185,676 | -1.22 | -33.42% |
| 3 Years | 10.21 | 34.10 | 1.08 | 6.98 | 110,185 | -7.78 | -76.2% |
| 5 Years | 8.55 | 34.10 | 1.08 | 6.98 | 109,929 | -6.12 | -71.58% |
Acer Therapeutics Description
| Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes three categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease. |
